Modulation of cerebral malaria by curcumin as an adjunctive therapy
Braz. j. infect. dis
; 17(5): 579-591, Sept.-Oct. 2013. ilus, tab
Artículo
en Inglés
| LILACS
| ID: lil-689884
Biblioteca responsable:
BR1.1
ABSTRACT
Cerebral malaria is the most severe and rapidly fatal neurological complication of Plasmodium falciparum infection and responsible for more than two million deaths annually. The current therapy is inadequate in terms of reducing mortality or post-treatment symptoms such as neurological and cognitive deficits. The pathophysiology of cerebral malaria is quite complex and offers a variety of targets which remain to be exploited for better therapeutic outcome. The present review discusses on the pathophysiology of cerebral malaria with particular emphasis on scope and promises of curcumin as an adjunctive therapy to improve survival and overcome neurological deficits.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Bases de datos:
LILACS
Métodos Terapéuticos y Terapias MTCI:
Terapias Biológicas
/
Aromaterapia
/
Plantas Medicinales
Asunto principal:
Adyuvantes Farmacéuticos
/
Malaria Cerebral
/
Curcumina
/
Antimaláricos
Límite:
Humanos
Idioma:
Inglés
Revista:
Braz. j. infect. dis
Asunto de la revista:
Enfermedades Transmisibles
Año:
2013
Tipo del documento:
Artículo
País de afiliación:
India
Institución/País de afiliación:
J.S.S. College of Pharmacy/IN
Similares
MEDLINE
...
LILACS
LIS